dc.date.accessioned | 2022-02-28T09:36:56Z | |
dc.date.available | 2022-02-28T09:36:56Z | |
dc.date.created | 2021-10-25T09:26:09Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Storeng, Katerini Tagmatarchi de Bengy Puyvallée, Antoine Stein, Felix . COVAX and the rise of the ‘super public private partnership’ for global health. Global Public Health. 2021 | |
dc.identifier.uri | http://hdl.handle.net/10852/91578 | |
dc.description.abstract | COVAX, the vaccines pillar of the Access to Covid-19 Tools Accelerator (ACT-A), has been promoted as ‘the only global solution' to vaccine equity and ending the Covid-19 pandemic. ACT-A and COVAX build on the public-private partnership (PPP) model that dominates global health governance, but take it to a new level, constituting an experimental form that we call the ‘super-PPP'. Based on an analysis of COVAX's governance structure and its difficulties in achieving its aims, we identify several features of the super-PPP model. First, it aims to coordinate the fragmented global health field by bringing together existing PPPs in an extraordinarily complex Russian Matryoshka doll-like structure. Second, it attempts to scale up a governance model designed for donor-dependent countries to tackle a health crisis affecting the entire world, pitting it against the self-interest of its wealthiest government partners. Third, the super-PPP's structural complexity obscures the vast differences between constituent partners, giving pharmaceutical corporations substantial power and making public representation, transparency, and accountability elusive. As a super-PPP, COVAX reproduces and amplifies challenges associated with the established PPPs it incorporates. COVAX's limited success has sparked a crisis of legitimacy for the voluntary, charity-based partnership model in global health, raising questions about its future. | |
dc.language | EN | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.title | COVAX and the rise of the ‘super public private partnership’ for global health | |
dc.type | Journal article | |
dc.creator.author | Storeng, Katerini Tagmatarchi | |
dc.creator.author | de Bengy Puyvallée, Antoine | |
dc.creator.author | Stein, Felix | |
cristin.unitcode | 185,0,0,0 | |
cristin.unitname | Universitetet i Oslo | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 1948112 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Global Public Health&rft.volume=&rft.spage=&rft.date=2021 | |
dc.identifier.jtitle | Global Public Health | |
dc.identifier.startpage | 1 | |
dc.identifier.endpage | 17 | |
dc.identifier.pagecount | 17 | |
dc.identifier.doi | https://doi.org/10.1080/17441692.2021.1987502 | |
dc.identifier.urn | URN:NBN:no-94170 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 1744-1692 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/91578/1/17441692.2021.pdf | |
dc.type.version | PublishedVersion | |
dc.relation.project | NFR/301929 | |